prevalence of factor viii inhibitor in patients with hemophilia a in sanandaj
نویسندگان
چکیده
background: factor viii inhibitor is one of the most problems in the treatment of hemophilia. patients with hemophilia who have inhibitors are capable of severe hemorrhage and treatments of these patients are more expensive and more difficult than those patients without inhibitor. the aim of present study was to determine the prevalence of inhibitor and to assess the necessity of screening of the factor viii inhibitors in hemophilia patients. methods: 104 patients with hemophilia a referred to besat hospital of sanandaj during 2006-2009 were evaluated for inhibitors against factor viii using convenient sampling method. their venous blood samples were mixed in a proportion of 9 to 1 with 3.2g/dl citrate sodium. after preparation of plasma aptt mix test and then bethesda test followed by determination of inhibitor were performed. results: the mean age of subjects was 23.8-±9.3 year. twenty out of 104 patients with hemophilia a (19.2%) had inhibitor factor viii. none of patients were assayed for inhibitor previously. sixteen patients were low responder and four patients showed high responder with the bethesda inhibitor level above five unit. higher levels of inhibitor were existed in 11-25 years old age groups. there was no significant relationship between factor viii inhibitor and patient's age. conclusion: regarding to high prevalence of the factor viii inhibitor in these patients, screening all hemophilia a patients every 6 months and doing bethesda test for new identified cases with this inhibitor is highly recommended.
منابع مشابه
Detection of Factor VIII Inhibitors in Hemophilia A Patients
Background: Factor VIII administration to hemophilia A patients results in an immune response (inhibitor formation) which significantly complicates the therapy. The present study was performed to determine the prevalence of inhibitor development in hemophilia A patients receiving recombinant factor VIII therapy. Materials and Methods: This was an observational descriptive study. Clotting fac...
متن کاملCoagulation Therapy in Hemophilia A and its Relation to Factor VIII Inhibitor in Northeast of Iran
متن کامل
FACTOR V AND VIII INHIBITOR IN PATIENTS WITH COMBINED FACTOR V AND VIII DEFICIENCY
Patients with coagulation factor(s) deficiency who use coagulation therapy are susceptible to forming inhibitors against coagulation factor(s). In this survey we detected factor V and VIII inhibitor in ten patients with combined deficiency of factors V and VIII from north east of Iran (Khorassan province). It was revealed in our survey that eight patients had both factor V and factor VIII i...
متن کاملIdiopathic Acquired Hemophilia A with Undetectable Factor VIII Inhibitor
Objective. We present the case of a 73-year-old female, with no family or personal history of a bleeding disorder, who had a classic presentation for acquired hemophilia A. Factor VIII activity was low but detectable and a factor VIII inhibitor was undetectable. Methods. The patient's plasma was comprehensively studied to determine the cause of the acquired coagulopathy. Using the Nijmegen modi...
متن کاملdetection of factor viii inhibitors in hemophilia a patients
background: factor viii administration to hemophilia a patients results in an immune response (inhibitor formation) which significantly complicates the therapy. the present study was performed to determine the prevalence of inhibitor development in hemophilia a patients receiving recombinant factor viii therapy. materials and methods: this was an observational descriptive study. clotting factor...
متن کاملfactor v and viii inhibitor in patients with combined factor v and viii deficiency
patients with coagulation factor(s) deficiency who use coagulation therapy are susceptible to forming inhibitors against coagulation factor(s). in this survey we detected factor v and viii inhibitor in ten patients with combined deficiency of factors v and viii from north east of iran (khorassan province). it was revealed in our survey that eight patients had both factor v and factor viii inhib...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
مجله دانشگاه علوم پزشکی کرمانشاهجلد ۱۵، شماره ۲، صفحات ۰-۰
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023